JCRB0224 WiDr
Cell information
Important Notice(s)JCRB0224, IFO50043 WiDr is derivative from HT-29.
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0224 | Cell Name | WiDr |
---|---|---|---|
Profile | adenocarcinoma | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | Age | ||
Identity | available | Tissue for Primary Cancer | colon |
Case history | Metastasis | ||
Tissue Metastasized | Genetics | colon, adenocarcinoma | |
Life Span | infinite | Crisis PDL | |
Morphology | Character | colon, adenocarcinoma | |
Classify | Established by | Wallace,R. | |
Registered by | Egashira, Y. | Regulation for Distribution | |
Comment | Year | 1987 | |
Medium | Dulbecco's modified Eagle's medium with 10% fetal calf serum | Methods for Passages | Cells are treated with 0.25% trypsin. |
Cell Number on Passage | 2x10^4 cells/ml | Race | |
CO2 Conc. | 5 % | Tissue Sampling | colon |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:14720324 | Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Onogawa S,Kitadai Y,Tanaka S,Kuwai T,Kimura S,Chayama K Cancer Sci. 2004 Jan;95(1):32-9 |
Pubmed id:698934 | Antiproliferative agents and differential survival between normal and cancer cells. Tsuboi KK,Kwong LK Cancer Res. 1978 Nov;38(11 Pt 1):3745-50 |
Images |
---|
LOT Information
Cell No. | JCRB0224 | Cell Name | WiDr |
---|---|---|---|
LOT No. | 06302010 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA027K03911) | Temperature | 37 C |
Cell Density at Seeding | 1.5-4.0x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.34x10^6 |
Viability at cell freezing (%) | 96.6 | Antibiotics Used | free |
Passage Number | p11 | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:11,12 D13S317:11 D7S820:10 D16S539:11,12 VWA:17,19 TH01:6,9 AM:X TPOX:8,9 CSF1PO:11,12 |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB0224 | Cell Name | |
---|---|---|---|
LOT No. | 04172008 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS Lot; GIBCO Cat. No. 10099, Lot 484375) | Temperature | 37 C |
Cell Density at Seeding | approx. 1 x 10^5 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA. Passage twice a week. |
Doubling Time | approx. 24 hrs | Cell Number in Vial (cells/1ml) | 8.1 x 10^6 |
Viability at cell freezing (%) | 97.5 | Antibiotics Used | free |
Passage Number | P13 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0224 | Cell Name | WiDr |
---|---|---|---|
LOT No. | 050995 | Lot Specification | distribution |
Medium | Eagle's minimal essential medium with non-essential amino acids (Gibco 27K6643) and 10% FBS. | Temperature | 37 C |
Cell Density at Seeding | 2.41x10^5 cells/ml | Methods for Passages | Cells are treated with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.1x10^6 |
Viability at cell freezing (%) | 97.3 | Antibiotics Used | free |
Passage Number | P9 | PDL | NT |
Sterility: MYCOPLASMA | NT | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0224 | Cell Name | |
---|---|---|---|
LOT No. | 040698 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal calf serum (FCS lot; BioWhittaker 6M0121) | Temperature | 37 C |
Cell Density at Seeding | 1.0-1.5 x 10^5 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
Doubling Time | 32-36 hrs | Cell Number in Vial (cells/1ml) | 8.4 x 10^6 |
Viability at cell freezing (%) | 94.0 | Antibiotics Used | free |
Passage Number | P3* | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |